Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Background

Ethacrynic acid is a dynamic agent holding alpha-beta unsaturated carbonyl unit in its structure which imparts superiority and extraordinary advantage of displaying multiple biological activities such as anticancer, antiviral, anti-malarial effect, diuretic effect and inhibits the Glutathione-s-transferase p1-1 enzyme which produces hindrance in the pathway of apoptosis. Ethacrynic acid is an inhibitor of Glutathione-s-transferases. EtA by itself act as an anti-cancer agent at higher concentration and also increases effectiveness of other compounds used in cancer treatment by preventing their detoxification, all these facts attracted our attention to develop and evaluate novel structural analogues of ethacrynic acid for their inhibitory effect on GSTs and anti-cancer activity in breast cancer.

Objective

By attending rational drug design perspectives the research is aimed to develop and evaluate novel structural analogues of ethacrynic acid as Inhibitors of GSTs enzyme and with anti-breast cancer activity.

Methods

Designed compounds were synthesized as per convenient route shown in the scheme of synthesis. Molecular docking studies were done against GSTP1-1 (PDB:3HJO). Structures of novel synthesized molecules were confirmed by spectral characterization such as FTIR, 1HNMR, 13CNMR and Mass spectrometry. ADME studies were done to ensure safety and drug like properties of the compounds. Ten structural analogues of ethacrynic acid were synthesized and evaluated for their inhibitory effect on activity of Glutathione-s-transferases which was measured by performing assay method. - anti-breast cancer activity was done on MCF-7 and MDAMB-231 cell line by MTT assay.

Results

Compound and were found with greater inhibition of the activity of GSTs and maximum anti-proliferative activity in breast cancer.

Conclusion

We have effectively developed novel compounds possessing structural resemblance with ethacrynic acid Compounds of the series has shown moderate to higher inhibitory effect on GSTs and anti-proliferative activity in breast cancer. The compound was found to be promising agent with high level of potency in each biological response. The research studies presented here may be an enlightening path in development of novel therapeutic agents with high level of inhibition in the activity of GSTs and anti-breast cancer effect.

Loading

Article metrics loading...

/content/journals/mc/10.2174/0115734064316508240911032442
2024-09-26
2025-05-12
Loading full text...

Full text loading...

References

  1. HayesJ.D. FlanaganJ.U. JowseyI.R. Glutathione transferases.Annu. Rev. Pharmacol. Toxicol.2005451518810.1146/annurev.pharmtox.45.120403.095857 15822171
    [Google Scholar]
  2. TidefeltU. Elmhorn-RosenborgA. PaulC. HaoX.Y. MannervikB. ErikssonL.C. Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.Cancer Res.1992521232813285 1596886
    [Google Scholar]
  3. HowellsR.E.J. DharK.K. HobanP.R. JonesP.W. FryerA.A. RedmanC.W.E. StrangeR.C. Association between glutathione- S -transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer.Int. J. Gynecol. Cancer200414224225010.1136/ijgc‑00009577‑200403000‑00010 15086723
    [Google Scholar]
  4. McIlwainC.C. TownsendD.M. TewK.D. Glutathione S-transferase polymorphisms: Cancer incidence and therapy.Oncogene200625111639164810.1038/sj.onc.1209373 16550164
    [Google Scholar]
  5. OakleyA.J. BelloM.L. BattistoniA. RicciG. RossjohnJ. VillarH.O. ParkerM.W. The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.J. Mol. Biol.199727418410010.1006/jmbi.1997.1364 9398518
    [Google Scholar]
  6. PloemenJ.H.T.M. OmmenB.V. BogaardsJ.J.P. Van BladerenP.J. Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S -transferases.Xenobiotica199323891392310.3109/00498259309059418 8284946
    [Google Scholar]
  7. SauA. PellizzariT.F. ValentinoF. FedericiG. CaccuriA.M. Glutathione transferases and development of new principles to overcome drug resistance.Arch. Biochem. Biophys.2010500211612210.1016/j.abb.2010.05.012 20494652
    [Google Scholar]
  8. AizawaS. OokawaK. KudoT. AsanoJ. HayakariM. TsuchidaS. Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD‐1 and suppression by N ‐acetyl‐ L ‐cysteine.Cancer Sci.2003941088689310.1111/j.1349‑7006.2003.tb01371.x 14556662
    [Google Scholar]
  9. O’DwyerP.J. LaCretaF. NashS. TinsleyP.W. SchilderR. ClapperM.L. TewK.D. PantingL. LitwinS. ComisR.L. ComisR.L. ComisR.L. PhaseI. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.Cancer Res.1991512260596065 1933869
    [Google Scholar]
  10. WardW.M. HoffmanJ.D. LooG. Genotoxic effect of ethacrynic acid and impact of antioxidants.Toxicol. Appl. Pharmacol.20152861172610.1016/j.taap.2015.03.016 25817893
    [Google Scholar]
  11. van IerselM.L.P.S. van LipzigM.M.H. RietjensI.M.C.M. VervoortJ. van BladerenP.J. GSTP1‐1 stereospecifically catalyzes glutathione conjugation of ethacrynic acid.FEBS Lett.1998441115315710.1016/S0014‑5793(98)01546‑4 9877184
    [Google Scholar]
  12. AliS.A. Diuretic effect of novel structural analogues of ethacrynic acid.Eur. J. Biomed. Pharmaceut. Sci.202293308316
    [Google Scholar]
  13. LiuB. HuangX. HuY. ChenT. PengB. GaoN. JinZ. JiaT. ZhangN. WangZ. JinG. Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer.Oncotarget2016736580385805010.18632/oncotarget.10846 27487128
    [Google Scholar]
  14. ZhaoG. YuT. WangR. WangX. JingY. Synthesis and structure–activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.Bioorg. Med. Chem.200513124056406210.1016/j.bmc.2005.03.046 15911318
    [Google Scholar]
  15. MokaleS.N. BegumA. SakleN.S. ShelkeV.R. BhavaleS.A. Design, synthesis and anticancer screening of 3-(3-(substituted phenyl)acryloyl)-2H-chromen-2ones as selective anti-breast cancer agent.Biomed. Pharmacother.20178996697210.1016/j.biopha.2017.02.089 28292025
    [Google Scholar]
  16. FriesnerR.A. MurphyR.B. RepaskyM.P. FryeL.L. GreenwoodJ.R. HalgrenT.A. SanschagrinP.C. MainzD.T. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.J. Med. Chem.200649216177619610.1021/jm051256o 17034125
    [Google Scholar]
  17. LipinskiC.A. LombardoF. DominyB.W. FeeneyP.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv. Drug Deliv. Rev.2001461-332610.1016/S0169‑409X(00)00129‑0 11259830
    [Google Scholar]
  18. HabigW.H. JakobyW.B. Assays for differentiation of glutathione S-Transferases.Methods Enzymol.19817739840510.1016/S0076‑6879(81)77053‑8 7329316
    [Google Scholar]
  19. GrubczakK. Kretowska-GrunwaldA. GrothD. PoplawskaI. EljaszewiczA. BolkunL. StaroszA. HollJ.M. MysliwiecM. KruszewskaJ. WojtukiewiczM.Z. MoniuszkoM. Differential response of MDA-MB-231 and MCF-7 breast cancer cells to in vitro inhibition with CTLA-4 and PD-1 through cancer-immune cells modified interactions.Cells2021108204410.3390/cells10082044 34440813
    [Google Scholar]
/content/journals/mc/10.2174/0115734064316508240911032442
Loading
/content/journals/mc/10.2174/0115734064316508240911032442
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test